2022 annual financial data
Lakefront Biotherapeutics 2022 Operating margin
Lakefront Biotherapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -54.32%.
Operating income was -131,057,000 EUR and net income was -217,991,000 EUR.
Operating cash flow was -500,544,000 EUR.
Get free Lakefront Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 241,249,000 EUR
- Operating income
- -131,057,000 EUR
- Net income
- -217,991,000 EUR
- Operating cash flow
- -500,544,000 EUR